How much does Apremilast cost? Price reference and market information for patients when purchasing

Apremilast is an oral small molecule PDE4 inhibitor mainly used to treat psoriatic arthritis, moderate to severe plaque psoriasis and oral ulcer-type Behcet's disease. At present, Apremilast has been officially launched in China and has been included in the national medical insurance directory, which means that patients who meet the medical insurance drug conditions can enjoy a certain proportion of medical insurance reimbursement when purchasing the drug in the hospital, thereby reducing the financial burden. Since medical insurance policies vary slightly from place to place, it is recommended that patients go to the pharmacies of tertiary hospitals or dermatology hospitals in their cities for specific consultation and drug purchase.

For patients who do not have medical insurance or do not meet the medical insurance drug requirements, if they choose to purchase the original Apremilast drug at their own expense in China, the price will still be relatively high. According to current market conditions, a box of Apremilast’s original version of the drug may cost more than 10,000 yuan, which is a considerable expense for patients who need to maintain medication for a long time. Therefore, some patients will consider purchasing Apremilast through overseas channels, especially the more competitively priced generic version.

In overseas markets, Apremilast's generic drugs mainly come from countries such as India and Laos. These generic drugs are produced by regular local pharmaceutical companies and have been approved for marketing by the corresponding national drug regulatory agencies. The ingredients of the drugs are basically the same as the original drugs and the efficacy is similar. At present, the price of generic Apremilast drugs in India and Laos is generally several hundred yuan per box, and the price/performance ratio is significantly higher than that of the original drug. This is a more practical and safe alternative for patients under financial pressure.

It should be noted that regardless of whether they choose domestic medical insurance channels or purchase overseas, patients should use Apremilast under the guidance of a professional doctor and never change the dosage or stop taking the drug on their own. When purchasing medicines from overseas channels, you should also ensure that you purchase them through formal and qualified platforms or institutions to avoid buying fake medicines or products with substandard quality, which will affect the treatment effect. A correct understanding of the relationship between price and drug efficacy can help patients make the most appropriate choice based on their own financial and treatment needs.

Reference materials:https://go.drugbank.com/drugs/DB05676